CDKN2A(p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade glioma
Sibin, M. K., Bhat, Dhananjaya I., Narasingarao, K. V. L., Lavanya, Ch., Chetan, G. K.Volume:
36
Language:
english
Journal:
Tumor Biology
DOI:
10.1007/s13277-015-3480-5
Date:
October, 2015
File:
PDF, 352 KB
english, 2015